Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo-controlled double-blind trial of erythropoietin in adult patients with Friedreich's ataxia
2007-003357-85Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Friedreich ataxia (FA) comparing rhuEPO with Placebo (2 arms). Primary endpoints: Safety and tolerability of rhuEPO and Change in frataxin protein levels in peripheral blood lymphocytes. Started Nov 2007; status: completed.
02
Drugs
erythropoietin
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2007-003357-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003357-85.